We can save your selected studies locally in your browser to enhance your experience. This data stays on your device and is not shared with us or third parties. You can clear this data at any time.
Description:
To prospectively evaluate the radiodrug biodistribution of a novel PET imaging agent [18F]AlF-PSMA-N5 in different organs of prostate cancer patients and its diagnostic efficacy in the diagnosis, recurrence and metastasis of prostate cancer, and to compare with [18F]F-DCFPyL.
Sponsor:
Anhui Provincial Hospital
Contacts:
Qiang Xie, MDxieqiang1980@ustc.edu.cn
13721108043
Government Study Link:
NCT06756334 - Click here to see study onClinicalTrials.gov